Aditxt, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Aditxt, Inc. (ADTX) reported Increase (Decrease) in Other Noncurrent Liabilities of $667.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2025-11-18
- Aditxt, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2024-12-31 was $0.00.
- Aditxt, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2024-09-30 was -$53.00K.
- Aditxt, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-12-31 was $0.00.
- Aditxt, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $667.00K, a 58.31% decline from fiscal 2023.
- Aditxt, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $1.60M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$53.00K derived: sum of 2 quarters · filed 2025-11-18 | $667.00K 10-K · filed 2025-03-31 | |
| 2024-09-30 | -$53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $667.00K 10-Q · filed 2025-11-18 | ||
| 2024-06-30 | $720.00K 10-Q · filed 2024-08-19 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.60M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $1.60M 10-Q · filed 2024-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |